activity
20212026
most citedStatistical Considerations for Cross-Sectional HIV Incidence Estimation Based on Recency Test

9 citations · 15 across the 10 of their papers we have counts for

collaborators

11 papers

stat.ME2026

The RobinCar Family: R Tools for Robust Covariate Adjustment in Randomized Clinical Trials

Marlena Bannick, Yuanyuan Bian, Gregory Chen +6

Purpose: Covariate adjustment is a powerful statistical technique that can increase efficiency in clinical trials. Recent guidance from the U.S. FDA provided recommendations and be…

stat.ME2024

Estimating HIV Cross-sectional Incidence Using Recency Tests from a Non-representative Sample

Jianan Pan, Marlena Bannick, Fei Gao

Cross-sectional incidence estimation based on recency testing has become a widely used tool in HIV research. Recently, this method has gained prominence in HIV prevention trials to…

stat.ME2024

Robust Nonparametric Stochastic Frontier Analysis

Peng Zheng, Nahom Worku, Marlena Bannick +4

Benchmarking tools, including stochastic frontier analysis (SFA), data envelopment analysis (DEA), and its stochastic extension (StoNED) are core tools in economics used to estimat…

stat.ME2023

An Enhanced Cross-Sectional HIV Incidence Estimator that Incorporates Prior HIV Test Results

Marlena Bannick, Deborah Donnell, Richard Hayes +2

Incidence estimation of HIV infection can be performed using recent infection testing algorithm (RITA) results from a cross-sectional sample. This allows practitioners to understan…

math.ST2023

Improved convergence rates of nonparametric penalized regression under misspecified total variation

Marlena S. Bannick, Noah Simon

Penalties that induce smoothness are common in nonparametric regression. In many settings, the amount of smoothness in the data generating function will not be known. Simon and Sho…

stat.ME2023★ 3 cited

A General Form of Covariate Adjustment in Randomized Clinical Trials

Marlena S. Bannick, Jun Shao, Jingyi Liu +3

In randomized clinical trials, adjusting for baseline covariates can improve credibility and efficiency for demonstrating and quantifying treatment effects. This article studies th…

stat.ME2023★ 2 cited

Robust Variance Estimation for Covariate-Adjusted Unconditional Treatment Effect in Randomized Clinical Trials with Binary Outcomes

Ting Ye, Marlena Bannick, Yanyao Yi +1

To improve precision of estimation and power of testing hypothesis for an unconditional treatment effect in randomized clinical trials with binary outcomes, researchers and regulat…

stat.ME2022

Accounting for Inconsistent Use of Covariate Adjustment in Group Sequential Trials

Marlena S. Bannick, Sonya L. Heltshe, Noah Simon

Group sequential designs in clinical trials allow for interim efficacy and futility monitoring. Adjustment for baseline covariates can increase power and precision of estimated eff…

stat.AP2022

Retrospective, Observational Studies for Estimating Vaccine Effects on the Secondary Attack Rate of SARS-CoV-2

Marlena S. Bannick, Fei Gao, Elizabeth R. Brown +1

COVID-19 vaccines are highly efficacious at preventing symptomatic infection, severe disease, and death. Most of the evidence that COVID-19 vaccines also reduce transmission of SAR…

stat.ME2021★ 1 cited

Analysis and Methods to Mitigate Effects of Under-reporting in Count Data

Jennifer Brennan, Marlena Bannick, Nicholas Kassebaum +4

Under-reporting of count data poses a major roadblock for prediction and inference. In this paper, we focus on the Pogit model, which deconvolves the generating Poisson process fro…

stat.ME2021★ 9 cited

Statistical Considerations for Cross-Sectional HIV Incidence Estimation Based on Recency Test

Fei Gao, Marlena S. Bannick

Longitudinal cohorts to determine the incidence of HIV infection are logistically challenging, so researchers have sought alternative strategies. Recency test methods use biomarker…